2015
DOI: 10.1016/j.remnie.2015.07.001
|View full text |Cite
|
Sign up to set email alerts
|

111In-octreotide SPECT–CT in head and neck paragangliomas

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2017
2017
2017
2017

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 7 publications
0
2
0
Order By: Relevance
“…Paragangliomas are low incidence neuroendocrine tumors that express somatostatin receptors, being type 2 the most common of them [1,2]. They arise from the neural crest of the autonomic nervous system and are usually benign slow growing lesions, which can produce compressive clinic or neurological dysfunction due to an involvement of adjacent nerves.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Paragangliomas are low incidence neuroendocrine tumors that express somatostatin receptors, being type 2 the most common of them [1,2]. They arise from the neural crest of the autonomic nervous system and are usually benign slow growing lesions, which can produce compressive clinic or neurological dysfunction due to an involvement of adjacent nerves.…”
Section: Introductionmentioning
confidence: 99%
“…Diagnosis is based on structural imaging tests such as magnetic resonance imaging (MRI), computed tomography (CT) or angiography and functional imaging tests, as 111 In-Pentetreotide scintigraphy. One of the main diagnostic indications of Nuclear Medicine tests is the suspicion of paragangliomas in areas of difficult biopsy access and/or in cases of atypical locations, which require differential diagnoses with other pathologies [1].…”
Section: Introductionmentioning
confidence: 99%